MedTrace Logo

Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2

NCT03586648 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2020-05-13

Study results available
· View outcomes & findings →

Summary

This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.

Conditions

  • Visual Acuity

Interventions

DEVICE

senofilcon A Multifocal

TEST Lens

DEVICE

senofilcon A Sphere

TEST Lens Sphere

DEVICE

etafilcon A Multifocal

CONTROL Lens

DEVICE

etafilcon A Sphere

CONTROL Lens Sphere

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-14
Primary Completion
2018-08-20
Completion
2018-08-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03586648 on ClinicalTrials.gov